神経刺激装置の市場規模、シェア、成長分析、製品別、用途別、地域別 - 産業予測 2025-2032年

神経刺激装置市場規模は2023年に59億8,000万米ドルと評価され、2024年の67億5,000万米ドルから2032年には176億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは12.8％で成長する見通しです。

神経刺激装置市場は、神経疾患の症例数の増加と関連研究への世界の投資の高まりにより、大きな成長が見込まれています。神経疾患に対する意識の高まりと効果的な治療に対する需要の増加は、この分野のプロバイダーに十分な機会を生み出しています。広範な調査による技術的進歩が神経刺激装置の売上を強化する一方、低侵襲手術への嗜好が市場の需要をさらに後押ししています。好意的な償還政策や神経刺激の利点に対する認識の高まりも、新たなビジネスチャンスをもたらしています。しかし、合併症のリスク、高額な機器コスト、熟練した専門家の不足といった課題は、当面の市場成長を妨げる可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

神経刺激装置市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 脊髄刺激装置
• 脳深部刺激装置
• 仙骨神経刺激装置
• 迷走神経刺激装置
• 胃電気刺激装置

神経刺激装置市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 疼痛管理
• てんかん
• 本態性振戦
• 尿失禁と便失禁
• うつ
• ジストニア
• 胃不全麻痺
• パーキンソン病
• その他

神経刺激装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Nevro Corporation（USA）
• LivaNova PLC（UK）
• NeuroPace, Inc.（USA）
• Neuronetics, Inc.（USA）
• Axonics Modulation Technologies, Inc.（USA）
• Cochlear Limited（Australia）
• ElectroCore, Inc.（USA）
• Aleva Neurotherapeutics SA（Switzerland）
• Soterix Medical（USA）
• Bioinduction（United Kingdom）
• Oticon Medical（Denmark）

結論と提言

Neurostimulation Devices Market size was valued at USD 5.98 billion in 2023 and is poised to grow from USD 6.75 billion in 2024 to USD 17.68 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The neurostimulation devices market is poised for significant growth driven by an increase in neurological disorder cases and heightened investments in related research globally. Rising awareness of neurological diseases and an increasing demand for effective treatments are creating ample opportunities for providers in this sector. Technological advancements from extensive research are set to enhance the sales of neurostimulation devices, while the preference for minimally invasive surgical procedures further supports market demand. Favorable reimbursement policies and growing recognition of the benefits of neurostimulation also present new business opportunities. However, challenges such as the risks of complications, high device costs, and a lack of skilled professionals may hinder market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurostimulation Devices Market Segments Analysis

Global Neurostimulation Devices Market is segmented by Product, Application and region. Based on Product, the market is segmented intoSpinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator and Gastric Electric Stimulator. Based on Application, the market is segmented into Pain Management, Epilepsy, Essential Tremor, Urinary & Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurostimulation Devices Market

The rising prevalence of neurological disorders has been greatly influenced by unhealthy lifestyle choices and the widespread adoption of detrimental habits. As the incidence of conditions such as Parkinson's disease, epilepsy, chronic pain, and depression continues to escalate, there is a correspondingly high demand for neurostimulation devices. These devices are essential in the management and treatment of various neurological ailments, making them vital for improving patient outcomes. Consequently, the increasing recognition of neurostimulation's effectiveness in alleviating symptoms and enhancing quality of life drives the market forward, underscoring the urgent need for innovative solutions in neuromodulation therapy.

Restraints in the Neurostimulation Devices Market

The neurostimulation devices market is grappling with a significant restraint due to the reliance on highly advanced medical technology, which necessitates the expertise of highly trained professionals for effective operation. Unfortunately, the current global landscape is experiencing a shortage of skilled healthcare providers, a trend that also adversely affects the neurostimulation sector. This lack of qualified personnel poses a potential barrier to the market's growth and development, as the limited availability of trained medical professionals may hinder the widespread adoption and utilization of these sophisticated devices, ultimately impacting their market expansion prospects in the future.

Market Trends of the Neurostimulation Devices Market

The neurostimulation devices market is increasingly embracing the trend of personalized medicine, reflecting a global shift towards tailored healthcare solutions. As awareness of individualized treatment options grows, these devices are being designed to adapt to the unique neurological patterns of patients, enhancing therapeutic effectiveness for conditions such as chronic pain and epilepsy. This customization not only improves patient outcomes but also fosters greater patient engagement and satisfaction. As technological advancements continue to unfold, the demand for such personalized neurostimulation solutions is expected to surge, positioning them as a pivotal component in the future landscape of neuromodulation therapies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Neurostimulation Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Spinal Cord Stimulator
• Deep Brain Stimulator
• Sacral Nerve Stimulator
• Vagus Nerve Stimulator
• Gastric Electric Stimulator

Global Neurostimulation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pain Management
• Epilepsy
• Essential Tremor
• Urinary & Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's Disease
• Others

Global Neurostimulation Devices Market Size & CAGR (2025-2032)

• North America (Product, Application)
  • US
  • Canada
• Europe (Product, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ElectroCore, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinduction (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oticon Medical (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations